InflaRx Update: Pipeline Continues To Progress, Data In 1H 2019

Enrollment has finished up for the phase 2b study evaluating IFX-1 in patients with moderate or severe Hidradenitis Suppurativa with data expected in …

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *